Status:
COMPLETED
Use of Incentives to Engage Drug Users in HIV Therapy
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Infection
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Highly active antiretroviral therapy (HAART), the current standard of care for treatment of HIV infection, is highly effective when taken appropriately. Before starting this treatment, a person must b...
Detailed Description
HAART eligibility screening entails presenting to the study site within 2 weeks of pre-screening, undergoing laboratory testing and providing a medical history, and returning for results within the su...
Eligibility Criteria
Inclusion
- Age 19 years or older
- Self-reports as having used illicit drugs within last 3 months
- Self-reports known or at-risk for HIV infection.
Exclusion
- Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
- Has lived in the greater Vancouver area for three months or less (as a means to enhance participant retention)
- Pregnancy
- Receipt of antiretroviral therapy within the last 12 months
- Known history of gambling addiction.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT01526421
Start Date
February 1 2012
End Date
September 1 2012
Last Update
December 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital, VIDUS study office site, 342 East Hastings
Vancouver, British Columbia, Canada